AI is Boosting Drug Discovery and Development — and Sparking Questions about Proprietary Data

In a panel discussion at Life Science Washington’s annual conference, Life Science Innovation Northwest, Danielle Greenawalt (Scientific Executive Director of Translational Informatics and Predictive Sciences, BMS), Lynda Stuart (Executive Director, Institute for Protein Design), Sean McClain (CEO, AbSci), Jonathan Cohen (Vice President of Applied Research, NVIDIA) and moderator Joseph Sirosh (former Chief Technology Officer of AI, Microsoft) discussed Washington state’s leadership role in AI and life sciences.